Aptose Announces Executive Management Changes
─ Appoints Philippe Ledru as Chief Commercial Officer ─ ─ Announces resignation of CFO/CBO Jotin Marango, MD, PhD ─ SAN...
Day: April 7, 2022
Jushi Holdings Inc. Completes NuLeaf, Inc. Acquisition and Expands Vertically Integrated Operations in Nevada
Increases Jushi’s Retail Footprint to Four Dispensaries in Nevada’s Attractive Limited License Retail Market Strengthens Existing Operations in the State...
XORTX Announces Grant of US Patent
Patent supporting Autosomal Dominant Polycystic Kidney Disease Granted – XRx-008 ProgramCALGARY, Alberta, April 07, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics...
ObsEva Annual General Meeting 2022
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland and Boston, MA – April 7, 2022 – ObsEva SA (NASDAQ:...
Immunocore to present at the 21st Annual Needham Healthcare Conference
Immunocore to present at the 21st Annual Needham Healthcare Conference (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 7...
Kizoo Portfolio Company Elastrin Therapeutics Inc. closes $10M Funding Round
Funding used to boost development and start clinical trials in humans in 2023GREENVILLE, S.C., April 07, 2022 (GLOBE NEWSWIRE) --...
Anavex Life Sciences to Present at the Needham Virtual Healthcare Conference
NEW YORK, April 07, 2022 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage...
Black Diamond Therapeutics Appoints Wendy L. Dixon to its Board of Directors
CAMBRIDGE, Mass. and NEW YORK, April 07, 2022 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology...
Sigilon Therapeutics to Present at the Needham Healthcare Conference
CAMBRIDGE, Mass., April 07, 2022 (GLOBE NEWSWIRE) -- Sigilon Therapeutics, Inc. (NASDAQ: SGTX), a biotechnology company that seeks to develop...
ProMIS Neurosciences Presents at the 2022 American Academy of Neurology Annual Meeting
TORONTO, Ontario and CAMBRIDGE, MA, April 07, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology...
ProMIS Files Management Information Circular in Connection with Annual General and Special Meeting of Shareholders
TORONTO, Ontario and CAMBRIDGE, Massachusetts, April 07, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (TSX: PMN) (OTCQB: ARFXF) (“ProMIS” or...
Tonix Pharmaceuticals Initiates Enrollment in the RESILIENT Study, a Potentially Pivotal Phase 3 Study of TNX-102 SL for the Management of Fibromyalgia
Results from Planned Interim Analysis Expected First Quarter 2023 A Positive Outcome in RESILIENT Together with Results from Previous Positive...
Xilio Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference
WALTHAM, Mass., April 07, 2022 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a biotechnology company developing tumor-selective immuno-oncology therapies...
Annexon Biosciences Completes Enrollment in ARCHER Phase 2 Trial of Novel C1q Inhibitor, ANX007, in Patients with Geographic Atrophy
Topline efficacy and safety data expected in first half of 2023BRISBANE, Calif., April 07, 2022 (GLOBE NEWSWIRE) -- Annexon, Inc....
Statutory restructuring plan adopted by creditors
Orphazyme A/S in restructuringCompany announcementNo. 20/2022Inside informationwww.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, April 7, 2022 – Orphazyme A/S in restructuring...
NTG Nordic Transport Group A/S – Annual General Meeting 2022
Company announcement no. 5 - 227 April 2022 NTG Nordic Transport Group A/S - Annual General Meeting 2022 Today, at...
Fourth annual Canadian Transplant Association Green Shirt Day in honour of Humboldt Broncos defenseman Logan Boulet encourages organ donation conversations and registrations
LETHBRIDGE, Alberta, April 07, 2022 (GLOBE NEWSWIRE) -- The fourth annual Green Shirt Day is led by the Boulet family...
Enochian BioSciences Announces Appointment of Senior Vice President for Clinical Operations with 32 Years’ Experience at Pfizer
LOS ANGELES, April 07, 2022 (GLOBE NEWSWIRE) -- Enochian BioSciences, Inc., (NASDAQ: ENOB), a company focused on gene-modified cellular and...
Reduction of GN Store Nord’s share capital
At GN Store Nord’s annual general meeting on March 9, 2022, it was decided to authorize the board of directors...
iOmx to Present New Pre-Clinical Data on SIK3 Checkpoint Inhibitor OMX-0407 at AACR 2022
MARTINSRIED / MUNICH, Germany, April 07, 2022 (GLOBE NEWSWIRE) -- iOmx Therapeutics AG (iOmx), a biopharmaceutical company developing cancer therapeutics...
